Why Meningitis That Hit Princeton Is Hard To Beat With Vaccines
There's been a lot of talk about meningitis B lately. That's the type of responsible for outbreaks at Princeton and the University of California in Santa Barbara.
And it got us thinking. How come this form of the illness isn't fazed by the vaccines given routinely to most young people in the U.S.?
This week, Princeton is administering an imported vaccine not approved for general use in this country, with special permission from the Food and Drug Administration.
The vaccine, called Bexsero, is fairly new. Swiss drug giant Novartis, which manufactures the vaccine, completed clinical trials early last year, and got approval to sell the vaccine in Europe last November.
Shots - Health News
To Fight Meningitis Outbreak, Princeton Tries European Vaccine